Lilach Koren

974 total citations
22 papers, 408 citations indexed

About

Lilach Koren is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Lilach Koren has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Lilach Koren's work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Signaling Pathways in Disease (3 papers). Lilach Koren is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Signaling Pathways in Disease (3 papers). Lilach Koren collaborates with scholars based in Israel, United States and United Kingdom. Lilach Koren's co-authors include Ami Aronheim, Tsonwin Hai, Avi Schroeder, Ofer Elhanani, Izhak Kehat, Galoz Kaneti, Roy Kalfon, Assaf Zinger, Janna Shainsky‐Roitman and Sharon Aviram and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Lilach Koren

17 papers receiving 400 citations

Peers

Lilach Koren
Xing Gao China
Lauren Bazinet United States
Deborah D. Chin United States
Jiayi Lin China
Ning Zeng China
Xing Gao China
Lilach Koren
Citations per year, relative to Lilach Koren Lilach Koren (= 1×) peers Xing Gao

Countries citing papers authored by Lilach Koren

Since Specialization
Citations

This map shows the geographic impact of Lilach Koren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Koren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Koren more than expected).

Fields of papers citing papers by Lilach Koren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Koren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Koren. The network helps show where Lilach Koren may publish in the future.

Co-authorship network of co-authors of Lilach Koren

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Koren. A scholar is included among the top collaborators of Lilach Koren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Koren. Lilach Koren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2024). Abstract 4762: Tumor treating fields (TTFields) increase cancer cell membrane permeability and improve sensitivity to doxorubicin in vitro and in vivo. Cancer Research. 84(6_Supplement). 4762–4762. 3 indexed citations
2.
Voloshin, Tali, Lilach Koren, Yiftah Barsheshet, et al.. (2024). Abstract 2030: N-cadherin-mediated activation of PI3K/Akt pathway following application of tumor treating fields (TTFields). Cancer Research. 84(6_Supplement). 2030–2030. 1 indexed citations
3.
Voloshin, Tali, et al.. (2023). P10.08.B PI3K INHIBITION FOR SENSITIZING CANCER CELLS TO TUMOR TREATING FIELDS (TTFIELDS). Neuro-Oncology. 25(Supplement_2). ii63–ii63.
4.
Poley, Maria, Patricia Mora‐Raimundo, Maya Kaduri, et al.. (2022). Nanoparticles Accumulate in the Female Reproductive System during Ovulation Affecting Cancer Treatment and Fertility. ACS Nano. 16(4). 5246–5257. 23 indexed citations
5.
Korach-Rechtman, Hila, Galoz Kaneti, Igor Nudelman, et al.. (2022). Lung targeted liposomes for treating ARDS. Journal of Controlled Release. 346. 421–433. 58 indexed citations
6.
Poley, Maria, Gal Chen, Aviram Avital, et al.. (2022). Sex‐Based Differences in the Biodistribution of Nanoparticles and Their Effect on Hormonal, Immune, and Metabolic Function. SHILAP Revista de lepidopterología. 2(12). 12 indexed citations
7.
Barsheshet, Yiftah, Tali Voloshin, Lilach Koren, et al.. (2022). Abstract 1305: Tumor Treating Fields (TTFields) promote a pro-inflammatory phenotype in macrophages. Cancer Research. 82(12_Supplement). 1305–1305. 2 indexed citations
8.
Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2021). EXTH-74. INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS). Neuro-Oncology. 23(Supplement_6). vi180–vi180. 1 indexed citations
10.
Barsheshet, Yiftah, et al.. (2021). 726 Tumor Treating Fields (TTFields) induce an altered polarization program in M1/M2 macrophages. SHILAP Revista de lepidopterología. A756–A756. 1 indexed citations
11.
Voloshin, Tali, et al.. (2021). Activated Phosphoinositide 3-Kinase/AKT/mTOR Signaling Confers Resistance to Tumor Treating Fields (TTFields). International Journal of Radiation Oncology*Biology*Physics. 111(3). e252–e252. 2 indexed citations
12.
Voloshin, Tali, Rosa S. Schneiderman, Reuben R. Shamir, et al.. (2020). Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics. Cancers. 12(10). 3016–3016. 63 indexed citations
13.
Koren, Lilach, Assaf Zinger, Zvi Yaari, et al.. (2019). Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin. Journal of Controlled Release. 296. 1–13. 70 indexed citations
14.
Kalfon, Roy, Tom Friedman, Rona Shofti, et al.. (2019). JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function. PLoS ONE. 14(2). e0213081–e0213081. 13 indexed citations
15.
Koren, Lilach, Uri Barash, Yaniv Zohar, N Karin, & Ami Aronheim. (2016). The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis. International Journal of Cardiology. 228. 394–400. 18 indexed citations
16.
Kalfon, Roy, et al.. (2016). ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance. Cardiovascular Research. 113(2). 134–146. 40 indexed citations
17.
Koren, Lilach, Dror Alishekevitz, Ofer Elhanani, et al.. (2015). ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling. International Journal of Cardiology. 198. 232–240. 24 indexed citations
18.
Koren, Lilach, Ofer Elhanani, Izhak Kehat, Tsonwin Hai, & Ami Aronheim. (2013). Adult Cardiac Expression of the Activating Transcription Factor 3, ATF3, Promotes Ventricular Hypertrophy. PLoS ONE. 8(7). e68396–e68396. 36 indexed citations
19.
Fuchs, Yaron, Mona Abed, Simona Zisman‐Rozen, et al.. (2012). Sef Is an Inhibitor of Proinflammatory Cytokine Signaling, Acting by Cytoplasmic Sequestration of NF-κB. Developmental Cell. 23(3). 611–623. 25 indexed citations
20.
Koren, Lilach, et al.. (2011). Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation. Biochemical Journal. 436(3). 661–669. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026